Treace Medical Concepts, Inc.(TMCI)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
TMCI is scheduled to report on Nov 10, 2026, after the market closes. Analysts expect EPS of -$0.26.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±19.1%).
Did the stock rise after good news?
The next-day move after each of its last 9 EPS beats and 2 misses.
In plain words: it beat expectations 9 times, but the stock still fell 5 of those 9 times.
- Aug '26Beat▲ +8.7%
- May '26Beat▲ +4.7%
- Feb '26Beat▼ -11.4%
- Nov '25Beat▼ -28.3%
- Aug '25Beat▲ +7.9%
- May '25Beat▼ -9.5%
- Nov '24Beat▲ +35.1%
- May '24Beat▼ -62.5%
- Feb '24Missed▼ -6.0%
- Nov '23Missed▼ -37.9%
- Aug '23Beat▼ -14.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did TMCI fall after beating earnings?
5 of TMCI's last 11 reactions went against the EPS result. What stands out in each:
TMCI beat EPS estimates in 9 quarters, and the stock still closed lower the next day 5 times. In 2 of the 5 where we have price data, the stock had already run up before the report.
- Feb 27, 2026EPS beat +42.9%stock -11.4% next day
- It had risen 9.4% in the final week before the report, so good news may already have been priced in.
- It opened 1.9% higher, but sellers took over and it closed -11.4%.
- Nov 6, 2025EPS beat +18.5%stock -28.3% next day
- It opened 37.4% lower as soon as trading resumed.
- May 8, 2025EPS beat +16.7%stock -9.5% next day
- It opened 9.8% lower as soon as trading resumed.
- May 7, 2024EPS beat +9.7%stock -62.5% next day
- It had risen 7.2% in the final week before the report, so good news may already have been priced in.
- It opened 59.5% lower as soon as trading resumed.
- Aug 8, 2023EPS beat +13.0%stock -14.4% next day
- It opened 1.2% lower as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was TMCI's earnings move already priced in?
TMCI's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does TMCI hold its opening gap after earnings?
TMCI's opening move after each report and where it closed that day.
In 12 reports TMCI opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 12 times (33%), and fully reversed 2 times. Gaps up faded 2 of 4; gaps down recovered 2 of 8.
- Aug 7, 2026HeldOpened +17.1%, closed +8.7%
- May 8, 2026FadedOpened +9.9%, closed +4.7%
- Feb 27, 2026ReversedOpened +1.9%, closed -11.4%
- Nov 6, 2025HeldOpened -37.4%, closed -28.3%
- Aug 7, 2025ReversedOpened -3.9%, closed +7.9%
- May 8, 2025HeldOpened -9.8%, closed -9.5%
- Nov 5, 2024HeldOpened +25.0%, closed +35.1%
- Aug 6, 2024HeldOpened -3.2%, closed -2.4%
What the history says
- TMCI has beaten EPS estimates in 7 straight quarters.
- It fell after 5 of its 9 EPS beats (56%): beating estimates has not been enough on its own.
TMCI earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Before open | -$0.30 | -$0.20 | +33.3% | +8.68% | +8.22% |
| May 8, 2026 | Before open | -$0.31 | -$0.12 | +61.3% | +4.69% | +19.53% |
| Feb 27, 2026 | Before open | -$0.14 | -$0.08 | +42.9% | -11.43% | -25.24% |
| Nov 6, 2025 | After close | -$0.27 | -$0.22 | +18.5% | -28.33% | -46.07% |
| Aug 7, 2025 | After close | -$0.29 | -$0.26 | +10.3% | +7.92% | +14.96% |
| May 8, 2025 | After close | -$0.30 | -$0.25 | +16.7% | -9.55% | -7.43% |
| Nov 5, 2024 | After close | -$0.26 | -$0.25 | +3.8% | +35.07% | +39.58% |
| Aug 6, 2024 | After close | -$0.28 | -$0.28 | 0.0% | -2.40% | -13.06% |
| May 7, 2024 | After close | -$0.31 | -$0.28 | +9.7% | -62.50% | -60.61% |
| Feb 27, 2024 | After close | -$0.09 | -$0.10 | -11.1% | -5.98% | -6.68% |
| Nov 9, 2023 | After close | -$0.26 | -$0.28 | -7.7% | -37.90% | -27.10% |
| Aug 8, 2023 | After close | -$0.23 | -$0.20 | +13.0% | -14.36% | -17.83% |
Consensus for the next report: EPS -$0.26, revenue $48.76M.
TMCI Earnings FAQ
Answers computed from Treace Medical Concepts, Inc.'s reported history
TMCI is scheduled to report on Nov 10, 2026, after the market closes. Analysts expect EPS of -$0.26.
Over the last 12 quarters with a usable EPS surprise, TMCI beat the consensus estimate 9 times (75%), missed 2 and landed in line 1. It has beaten estimates in each of the last 7 counted quarters.
Across its last 12 quarters with a measured reaction, TMCI moved an average of ±19.1% in the first session after reporting. It closed higher 33% of the time; the largest gain was 35.1% and the largest drop -62.5%.
TMCI fell in the first session after 5 of its last 9 EPS beats (56%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 5 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, TMCI moved an average of -0.4% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging +1.4%. After a drop of 3% or more (5 quarters), it rose the next day 40% of the time, averaging -14.3%. This describes past reports; it is not a forecast.
In 12 reports TMCI opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 12 times (33%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · TMCI: 12 reported quarters, latest Aug 7, 2026. Information only, not investment advice.
Looking for more on TMCI?
Price charts, forecast, fundamentals and risk pages for TMCI are not on Tickzen yet. You can run a full stock analysis now.
Run the TMCI Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun